News & Updates

Show Multimedia Only

GLP-1RA plus progestin combo fends off endometrial cancer risk

09 Mar 2026 by

Concurrent use of a glucagon-like peptide-1 receptor agonist (GLP-1RA) and progestins appears to protect against the risk of endometrial cancer in women with benign uterine pathology or endometrial hyperplasia, according to a real-world study.

GLP-1RA plus progestin combo fends off endometrial cancer risk

09 Mar 2026

Healthy plant-based diets lower risk of colorectal, liver cancers

06 Mar 2026

High consumption of healthy plant foods and low intake of animal foods appear to reduce the risks of liver cancer and colorectal cancer (CRC), suggests a study. These associations seem partly mediated through gut microbiota and systemic metabolism.

Healthy plant-based diets lower risk of colorectal, liver cancers

06 Mar 2026

HPV vaccine protects females against several cancers

05 Mar 2026 by

Immunization against the human papillomavirus (HPV) can reduce the incidence of various cancer types in females 9 to 26 years of age, according to a study.

HPV vaccine protects females against several cancers

05 Mar 2026

Stool-based microbial test transforms colon cancer detection

05 Mar 2026 by

A stool-based microbial diagnostic test outperforms faecal immunochemical test (FIT) in detecting colorectal cancer (CRC) or advanced adenoma (polyps) in a study conducted in Hong Kong, Singapore and Japan.

Stool-based microbial test transforms colon cancer detection

05 Mar 2026

Extranodal extension predicts poor survival in HNSCC independent of nutritional status

04 Mar 2026 by

Extranodal extension (ENE) of lymph node metastases is a robust predictor of survival in head and neck squamous cell cancers (HNSCC) and appears to be independent of nutritional status, reports a study.

Extranodal extension predicts poor survival in HNSCC independent of nutritional status

04 Mar 2026

Social determinants of health tied to CNS tumour outcomes

04 Mar 2026

Several social determinants of health (SDoH) appear to influence paediatric central nervous system (CNS) tumour outcomes, suggests a study.

Social determinants of health tied to CNS tumour outcomes

04 Mar 2026

Is pembrolizumab plus RT safe to administer in TNBC?

03 Mar 2026

Combination treatment with pembrolizumab and adjuvant radiotherapy (RT) does not pose any serious risk to patients with triple-negative breast cancer (TNBC), showing no increase in radiation-related adverse events (AEs), a study has shown.

Is pembrolizumab plus RT safe to administer in TNBC?

03 Mar 2026

Sacituzumab tirumotecan feasible in advanced urothelial carcinoma

03 Mar 2026 by

Treatment with sacituzumab tirumotecan (sac-TMT) shows a promising antitumour activity and an acceptable safety profile in patients with heavily pretreated advanced or metastatic urothelial carcinoma (UC), according to a phase II study.

Sacituzumab tirumotecan feasible in advanced urothelial carcinoma

03 Mar 2026

Tucatinib-T-DM1 combo improves PFS in patients with metastatic breast cancer

03 Mar 2026 by

Treatment with trastuzumab emtansine (T-DM1) plus tucatinib safely prolongs progression-free survival (PFS) in patients with previously treated HER2-positive locally advanced (LA) or metastatic breast cancer (MBC), including those with brain metastases, reports a study.

Tucatinib-T-DM1 combo improves PFS in patients with metastatic breast cancer

03 Mar 2026

Original New Drug Application Approvals by US FDA (1-15 February 2026)

02 Mar 2026

New drug applications approved by US FDA as of 1-15 February 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (1-15 February 2026)

02 Mar 2026

News & Updates

Showing Oncology articles

Showing

Specialty:

GLP-1RA plus progestin combo fends off endometrial cancer risk

GLP-1RA plus progestin combo fends off endometrial cancer risk

Healthy plant-based diets lower risk of colorectal, liver cancers

Healthy plant-based diets lower risk of colorectal, liver cancers

HPV vaccine protects females against several cancers

HPV vaccine protects females against several cancers

Stool-based microbial test transforms colon cancer detection

Stool-based microbial test transforms colon cancer detection

Extranodal extension predicts poor survival in HNSCC independent of nutritional status

Extranodal extension predicts poor survival in HNSCC independent of nutritional status

Social determinants of health tied to CNS tumour outcomes

Social determinants of health tied to CNS tumour outcomes

Is pembrolizumab plus RT safe to administer in TNBC?

Is pembrolizumab plus RT safe to administer in TNBC?

Sacituzumab tirumotecan feasible in advanced urothelial carcinoma

Sacituzumab tirumotecan feasible in advanced urothelial carcinoma

Tucatinib-T-DM1 combo improves PFS in patients with metastatic breast cancer

Tucatinib-T-DM1 combo improves PFS in patients with metastatic breast cancer

Original New Drug Application Approvals by US FDA (1-15 February 2026)

Original New Drug Application Approvals by US FDA (1-15 February 2026)